Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929.

Ann Oncol

University Hospital (CHRU) Besançon, UMR1098 UBFC/EFS/INSERM, Immuno-Oncologie et Biotechnologies en Cancérologie, Besançon, France; EA4340-Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Versailles University, Boulogne, France; Ambroise Paré Hospital, AP-HP, Boulogne, France.

Published: September 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annonc.2020.06.013DOI Listing

Publication Analysis

Top Keywords

corrigendum 'prognostic
4
'prognostic predictive
4
predictive immunoscore
4
immunoscore stage
4
stage iii
4
iii colon
4
colon cancer
4
cancer patients
4
patients treated
4
treated oxaliplatin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!